CHANCELLOR MICHAEL B (Chief Medical Officer) reported 1 transaction at LIPELLA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/27/2022ACC: 0001753926-22-001648
DirectorOfficer10% Owner· Chief Medical Officer
Since Dec 2022
+22.95K
Net shares
Net buyer
$132.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.95K
Price / share
$5.75
Trade value
$131.96K
% of position
3.2%
12/22/2022
709.78K→732.73K
Total
Net shares
+22.95K
Net value
$131.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2022 | J · J | +22.95K | $5.75 | $131.96K | 3.2% | 709.78K | 732.73K |
| Total | +22.95K | $131.96K | ||||||
Derivative Transactions0
No derivative transactions reported